HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.

Abstract
Increased liver fat may be caused by insulin resistance and adipose tissue inflammation or by the common I148M variant in PNPLA3 at rs738409, which lacks both of these features. We hypothesised that obesity/insulin resistance rather than liver fat increases circulating coagulation factor activities. We measured plasma prothrombin time (PT, Owren method), activated partial thromboplastin time (APTT), activities of several coagulation factors, VWF:RCo and fibrinogen, and D-dimer concentration in 92 subjects divided into groups based on insulin sensitivity [insulin-resistant ('IR') versus insulin-sensitive ('IS')] and PNPLA3 genotype (PNPLA3148MM/MI vs PNPLA3148II). Liver fat content (1H-MRS) was similarly increased in 'IR' (13 ± 1 %) and PNPLA3148MM/MI (12 ± 2 %) as compared to 'IS' (6 ± 1 %, p<0.05) and PNPLA3148II (8 ± 1 %, p<0.05), respectively. FVIII, FIX, FXIII, fibrinogen and VWF:RCo activities were increased, and PT and APTT shortened in 'IR' versus 'IS', in contrast to these factors being similar between PNPLA3148MM/MI and PNPLA3148II groups. In subjects undergoing a liver biopsy and entirely lacking the I148M variant, insulin-resistant subjects had higher hepatic expression of F8, F9 and FGG than equally obese insulin-sensitive subjects. Expression of pro-inflammatory genes in adipose tissue correlated positively with PT (% of normal), circulating FVIII, FIX, FXI, VWR:RCo and fibrinogen, and expression of anti-inflammatory genes negatively with PT (%), FIX and fibrinogen. We conclude that obesity/insulin resistance rather than an increase in liver fat is associated with a procoagulant plasma profile. This reflects adipose tissue inflammation and increased hepatic production of coagulation factors and their susceptibility for activation.
AuthorsSusanna Lallukka, Panu K Luukkonen, You Zhou, Elina Isokuortti, Marja Leivonen, Anne Juuti, Antti Hakkarainen, Marju Orho-Melander, Nina Lundbom, Vesa M Olkkonen, Riitta Lassila, Hannele Yki-Järvinen
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 117 Issue 2 Pg. 286-294 (01 26 2017) ISSN: 2567-689X [Electronic] Germany
PMID27929200 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Blood Coagulation Factors
  • Cytokines
  • Inflammation Mediators
  • Membrane Proteins
  • Lipase
  • adiponutrin, human
Topics
  • Adipose Tissue (metabolism, pathology)
  • Adiposity
  • Adult
  • Biomarkers (blood)
  • Biopsy
  • Blood Coagulation
  • Blood Coagulation Factors (genetics, metabolism)
  • Cytokines (blood)
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Inflammation Mediators (blood)
  • Insulin Resistance
  • Lipase (genetics)
  • Liver (metabolism, pathology)
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease (blood, diagnosis, genetics)
  • Obesity (blood, diagnosis)
  • Partial Thromboplastin Time
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Prothrombin Time
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: